Primary Health Properties PLC

LSE:PHP.L

Sector

🏠 Real Estate

Industries

🩺 Health Care REITs

Location

United Kingdom

Market Cap

USD 1.82 B

Share Price

USD 1.36

Avg Daily Volume

4,720,564

Change (1 day)

0.81%

Change (1 year)

17.22%

Change (YTD)

16.62%

Primary Health Properties PLC Price to Earnings Ratio (P/E) on June 25, 2025: 35.13

Primary Health Properties PLC Price to Earnings Ratio (P/E) is 35.13 on June 25, 2025, a -22.13% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Primary Health Properties PLC 52-week low Price to Earnings Ratio (P/E) is 53.11 on June 25, 2025, which is 51.21% above the current Price to Earnings Ratio (P/E).
Primary Health Properties PLC 52-week low Price to Earnings Ratio (P/E) is 33.51 on June 25, 2025, which is -4.60% below the current Price to Earnings Ratio (P/E).
Primary Health Properties PLC average Price to Earnings Ratio (P/E) for the last 52 weeks is 44.47.

Daily

From:

To:

Zoom:

Key data

Date	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)	Enterprise Value to EBITDA (EV/EBITDA)

LSE: PHP.L

Primary Health Properties PLC

CEO	Mr. Mark Davies A.C.A.
IPO Date	March 19, 1996
Location	United Kingdom
Headquarters	Greener House
Employees	87
Sector	🏠 Real Estate
Industries Health Care REITs

Description

Primary Health Properties (PHP) is the leading investor in modern healthcare properties in the UK & Ireland. PHP is a UK based Real Estate Investment Trust (REIT) with a clear objective to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. PHP achieve this by investing in healthcare real estate let on long-term leases, backed by a secure underlying covenant funded mostly by government bodies. The Group's portfolio comprises over 480 primary healthcare facilities, both completed and committed, the majority of which are GP surgeries, with other properties let to NHS organisations, pharmacies and dentists.